New Horizon Europe Funding Boosts European Research in AI and Quantum Technologies

European CommissionThe European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in the realms of artificial intelligence (AI) and quantum technologies.

This includes substantial funding of €50 million fund to advance large AI models by integrating new data modalities and expanding their capabilities. This call targets the development of generative AI capable of processing and generating multimodal data, including but not limited to text, images, audio, video, and 3D representations, while adapting to a wide range of tasks and domains. With this funding, Europe aims to lead in creating AI systems that are not only powerful but also adhere to European values and ethical guidelines, particularly in view of the AI Act.

To address the need for transparency and robustness in AI €15 million will be invested in projects that will enhance the intelligibility and reliability of AI systems. The EU recognises the importance of AI systems that are not only intelligent but also understandable and safe for users, thus supporting the EU’s approach for human-centric AI.

€40 million will be invested to boost research into cutting-edge, world-leading quantum technologies. €25 million of this investment will be devoted to developing a network of quantum gravimeters throughout Europe. This will not only enhance precision in Earth observation and civil engineering. It will also show how quantum technologies can represent a significant improvement on current technological capabilities. The network will consist of at least eight gravimeters (gravity sensors), demonstrating how quantum gravimetry can offer much greater precision than its classical equivalent and serving as the basis for a future pan-European digital quantum sensing infrastructure.

In addition, there will be €15 million of investment focusing on stimulating transnational research and development in next-generation quantum technologies. These transnational research projects are expected to foster synergies among European stakeholders, ensuring that the EU remains at the forefront of the global quantum technology race, and cementing its position as a hub of innovation and technological self-reliance.

A further €6 million of investment aims to strengthen Europe's engagement in global ICT standardisation. By supporting the participation of European experts in international standard-setting bodies, the EU seeks to promote its interests and values in the development of global technical specifications and standards.

The remaining €1.5 million will see investment to explore Digital Humanism, a project that places people at the centre of the digital transformation. This approach emphasises the need for cross-disciplinary collaboration to ensure that the digital realm upholds European standards of law, social economy, and fundamental rights.

More information as regards the areas of activity for these calls (HORIZON-CL4-2024-DIGITAL-EMERGING-02, and HORIZON-CL4-2024-HUMAN-03) is available in the 2023-2025 Horizon Europe Digital, Industry, and Space work programme.

Most Popular Now

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Using AI to Uncover Hospital Patients�…

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may...

New AI Tool Uses Routine Blood Tests to …

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of...

New Method Tracks the 'Learning Cur…

Introducing Annotatability - a powerful new framework to address a major challenge in biological research by examining how artificial neural networks learn to label genomic data. Genomic datasets often contain...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...